HSCT is effective in patients with PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome.
Laberko A, Burlakov V, Maier S, Abinun M, Skinner R, Kozlova A, Suri D, Lehmberg K, Müller I, Balashov D, Novichkova G, Holzinger D, Gennery AR, Shcherbina A.
Laberko A, et al. Among authors: kozlova a.
J Allergy Clin Immunol. 2021 Jul;148(1):250-255.e1. doi: 10.1016/j.jaci.2020.11.043. Epub 2020 Dec 15.
J Allergy Clin Immunol. 2021.
PMID: 33338535